AAAAAA

   
Results: 1-25 | 26-46
Results: 1-25/46

Authors: HURLEN M SELJEFLOT I ARNESEN H
Citation: M. Hurlen et al., THE EFFECT OF DIFFERENT ANTITHROMBOTIC REGIMENS ON PLATELET-AGGREGATION AFTER MYOCARDIAL-INFARCTION, SC CARDIOVA, 32(4), 1998, pp. 233-237

Authors: JOHANSEN O BREKKE M STROMME JH VALEN V SELJEFLOT I SKJAEGGESTAD O ARNESEN H
Citation: O. Johansen et al., MYOCARDIAL DAMAGE DURING PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY AS EVIDENCED BY TROPONIN-T MEASUREMENTS, European heart journal, 19(1), 1998, pp. 112-117

Authors: ANDERSEN P SELJEFLOT I HERZOG A ARNESEN H HJERMANN I HOLME I
Citation: P. Andersen et al., EFFECTS OF DOXAZOSIN AND ATENOLOL ON ATHEROTHROMBOGENIC RISK PROFILE IN HYPERTENSIVE MIDDLE-AGED MEN, Journal of cardiovascular pharmacology, 31(5), 1998, pp. 677-683

Authors: SELJEFLOT I MOAN A ASPELIN T TONNESSEN T KJELDSEN SE ARNESEN H
Citation: I. Seljeflot et al., CIRCULATING LEVELS OF ENDOTHELIN-1 DURING ACUTE HYPERINSULINEMIA IN PATIENTS WITH ESSENTIAL-HYPERTENSION TREATED WITH TYPE-1 ANGIOTENSIN RECEPTOR ANTAGONIST OR PLACEBO, Metabolism, clinical and experimental, 47(3), 1998, pp. 292-296

Authors: SELJEFLOT I ARNESEN H BRUDE IR NENSETER MS DREVON CA HJERMANN I
Citation: I. Seljeflot et al., EFFECTS OF OMEGA-3-FATTY-ACIDS AND OR ANTIOXIDANTS ON ENDOTHELIAL-CELL MARKERS/, European journal of clinical investigation, 28(8), 1998, pp. 629-635

Authors: OS I SELJEFLOT I HOFSTAD A DJUROVIC S ARNESEN H
Citation: I. Os et al., HORMONE REPLACEMENT THERAPY IN WOMEN WITH CORONARY-ARTERY DISEASE REDUCES ENDOTHELIAL-CELL MARKERS - THE EWA STUDY, Circulation, 98(17), 1998, pp. 3467-3467

Authors: BRUDE IR DREVON CA HJERMANN I SELJEFLOT I LUNDKATZ S SAAREM K SANDSTAD B SOLVOLL K HALVORSEN B ARNESEN H NENSETER MS
Citation: Ir. Brude et al., PEROXIDATION OF LDL FROM COMBINED-HYPERLIPIDEMIC MALE SMOKERS SUPPLIED WITH (OMEGA)OVER-BAR-3 FATTY-ACIDS AND ANTIOXIDANTS, Arteriosclerosis, thrombosis, and vascular biology, 17(11), 1997, pp. 2576-2588

Authors: SELJEFLOT I JOHANSEN O EGGESBO JB KIERULF P ARNESEN H
Citation: I. Seljeflot et al., DECREASED PROCOAGULANT ACTIVITY AND IMPAIRED CYTOKINE EXPRESSION IN WHOLE-BLOOD CULTURES FROM PATIENTS WITH CORONARY HEART-DISEASE SUPPLEMENTED WITH N-3 FATTY-ACID, Thrombosis and haemostasis, 1997, pp. 464-464

Authors: ARNESEN H DAHL OE ASPELIN T SELJEFLOT I
Citation: H. Arnesen et al., PREDICTIVITY OF SERUM D-DIMER, A GLOBAL TEST OF FIBRINOLYSIS AN DEEP VENOUS THROMBOSIS AFTER HIP-REPLACEMENT SURGERY, Thrombosis and haemostasis, 1997, pp. 653-653

Authors: DAHL OE ASPELIN T ROISE O ARNESEN H LYBERG T
Citation: Oe. Dahl et al., CONCOMITANT USE OF DEXTRAN-70 (MACRODEX(R)) AND LOW-MOLECULAR-WEIGHT HEPARIN (DALTEPARIN) DO NOT INCREASE MAJOR ORTHOPEDIC-SURGERY RELATED PERIOPERATIVE BLEEDING COMPARED TO DEXTRAN-70 ALONE, Thrombosis and haemostasis, 1997, pp. 1188-1188

Authors: DAHL OE ANDREASSEN G ASPELIN T MULLER C MATHIESEN P NYHUS S ABDELNOOR M SOLHAUG JH ARNESEN H
Citation: Oe. Dahl et al., PROLONGED THROMBOPROPHYLAXIS FOLLOWING HIP-REPLACEMENT SURGERY - RESULTS OF A DOUBLE-BLIND, PROSPECTIVE, RANDOMIZED, PLACEBO-CONTROLLED STUDY WITH DALTEPARIN (FRAGMIN(R)), Thrombosis and haemostasis, 77(1), 1997, pp. 26-31

Authors: STEINE S LAERUM E ERITSLAND J ARNESEN H
Citation: S. Steine et al., PREDICTORS OF ENHANCED WELL-BEING AFTER CORONARY-ARTERY BYPASS-SURGERY, Journal of internal medicine, 239(1), 1996, pp. 69-73

Authors: MOAN A HOIEGGEN A SELJEFLOT I RISANGER T ARNESEN H KJELDSEN SE
Citation: A. Moan et al., THE EFFECT OF ANGIOTENSIN-II RECEPTOR ANTAGONISM WITH LOSARTAN ON GLUCOSE-METABOLISM AND INSULIN SENSITIVITY, Journal of hypertension, 14(9), 1996, pp. 1093-1097

Authors: SELJEFLOT I MOAN A KJELDSEN S SANDVIK E ARNESEN H
Citation: I. Seljeflot et al., EFFECT OF ANGIOTENSIN-II RECEPTOR BLOCKADE ON FIBRINOLYSIS DURING ACUTE HYPERINSULINEMIA IN PATIENTS WITH ESSENTIAL-HYPERTENSION, Hypertension, 27(6), 1996, pp. 1299-1304

Authors: SELJEFLOT I MOAN A TONNESSEN T KJELDSEN SE ARNESEN H
Citation: I. Seljeflot et al., EFFECTS OF HYPERINSULINEMIA AND ANGIOTENSIN-II RECEPTOR BLOCKAGE ON PLASMA ENDOTHELIN-1 IN PATIENTS WITH HYPERTENSION, Circulation, 94(8), 1996, pp. 1988-1988

Authors: ERITSLAND J ARNESEN H GRONSETH K FJELD NB ABDELNOOR M
Citation: J. Eritsland et al., EFFECT OF DIETARY SUPPLEMENTATION WITH N-3 FATTY-ACIDS ON CORONARY-ARTERY BYPASS GRAFT PATENCY, The American journal of cardiology, 77(1), 1996, pp. 31-36

Authors: ERITSLAND J ARNESEN H SELJEFLOT I KIERULF P
Citation: J. Eritsland et al., LONG-TERM EFFECTS OF N-3 POLYUNSATURATED FATTY-ACIDS ON HEMOSTATIC VARIABLES AND BLEEDING EPISODES IN PATIENTS WITH CORONARY-ARTERY DISEASE, Blood coagulation & fibrinolysis, 6(1), 1995, pp. 17-22

Authors: SEIGNEUR M JOHANSEN O ARNESEN H
Citation: M. Seigneur et al., EFFECTS OF OMEGA-3 POLYUNSATURATED FATTY-ACIDS (PUFA) ON VASCULAR ENDOTHELIAL-CELL MARKERS, Thrombosis and haemostasis, 73(6), 1995, pp. 908-908

Authors: SELJEFLOT I JOHANSEN O ARNESEN H
Citation: I. Seljeflot et al., EFFECTS OF OMEGA-3 POLYUNSATURATED FATTY-ACIDS (PUFA) ON VASCULAR ENDOTHELIAL-CELL MARKERS, Thrombosis and haemostasis, 73(6), 1995, pp. 908-908

Authors: DAHL OE ASPELIN T LYBERG T SELJEFLOT I KIERULF P RUYTER R ARNESEN H
Citation: Oe. Dahl et al., LOW INITIAL PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-I) RESPONSE ASSOCIATED WITH LATE DEEP VENOUS THROMBOSIS (DVT) AFTER HIP-REPLACEMENT SURGERY (HRS), Thrombosis and haemostasis, 73(6), 1995, pp. 1005-1005

Authors: DAHL OE ANDREASSEN G MULLER C MATHISEN P NYHUS S ASPELIN T SOLHAUG JH ABDELNOOR M ARNESEN H
Citation: Oe. Dahl et al., THE EFFECT OF PROLONGED THROMBOPROPHYLAXIS WITH DALTEPARIN ON THE FREQUENCY OF DEEP-VEIN THROMBOSIS (DVT) AND PULMONARY-EMBOLISM (PE) 35 DAYS AFTER HIP-REPLACEMENT SURGERY (HRS), Thrombosis and haemostasis, 73(6), 1995, pp. 1094-1094

Authors: ERITSLAND J GJONNES G SANDSET PM SELJEFLOT I ARNESEN H
Citation: J. Eritsland et al., ACTIVATED PROTEIN-C RESISTANCE - PREVALENCE AMONG PATIENTS UNDERGOINGCORONARY-ARTERY BYPASS-SURGERY AND RELATION TO SHUNT OCCLUSIONS, Thrombosis and haemostasis, 73(6), 1995, pp. 1374-1374

Authors: ERITSLAND J ARNESEN H SELJEFLOT I
Citation: J. Eritsland et al., DOES LONG-TERM WARFARIN THERAPY ADVERSELY AFFECT THE ATHEROGENIC LIPID PROFILE IN PATIENTS WITH CORONARY-ARTERY DISEASE, Thrombosis and haemostasis, 73(6), 1995, pp. 1390-1390

Authors: SELJEFLOT I ARNESEN H STOEN R LYBERG T
Citation: I. Seljeflot et al., EFFECTS OF INSULIN AND SOME VASOCONSTRICTORS ON THE SYNTHESIS AND RELEASE OF T-PA AND PAI-1 FROM CULTURED HUMAN UMBILICAL VEIN ENDOTHELIAL-CELLS, Fibrinolysis, 9(4), 1995, pp. 253-257

Authors: DAHL OE ASPELIN T ARNESEN H SELJEFLOT I KIERULF P RUYTER R LYBERG T
Citation: Oe. Dahl et al., INCREASED ACTIVATION OF COAGULATION AND FORMATION OF LATE DEEP VENOUSTHROMBOSIS FOLLOWING DISCONTINUATION OF THROMBOPROPHYLAXIS AFTER HIP-REPLACEMENT SURGERY, Thrombosis research, 80(4), 1995, pp. 299-306
Risultati: 1-25 | 26-46